AQST SG&A Expenses

Aquestive Therapeutics Inc · SG&A Expenses

AQST logo

AQST SG&A Expenses

Latest reported$73.11M
AQST SG&A Expenses ($20.80M → $73.11M)
High-resolution chart · PNG

AQST sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
79,849,000
50,180,000
31,750,000
52,879,000
53,475,000
55,892,000
64,342,000
72,264,000
25,078,000
20,804,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.